Cormorant Asset Management, LP

Q2 2026 13F-HR Holdings

Location
Boston, MA
Holdings as of
6/30/2026
Date filed
8/14/2026
Form type
13F-HR
Num holdings
50
Total value ($000)
$1,951,406
Net value change ($000)
-39,640 (-2.0%)
New positions
13
Sold out positions
9
Turnover %
19.3%
Sector allocation + QoQ delta (equities-only)

Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown

Prev filing: 5/15/2026 Next filing: — SEC filing

Snapshot: Change Analysis

Compared to Q1 2026
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
PARABILIS MEDICINES INC 126,329 NEW
CLYM 27,462 NEW
ANL 25,697 128.1%
ORKA 24,598 94.0%
BHVN 23,947 160.8%
SYRE 19,976 NEW
DFTX 18,816 NEW
RAPP 18,198 19.7%
ERAS 16,076 17.1%
Ascendis Pharma AS 13,336 NEW
Top Reduces (Value $000, Stocks/ETFs)
PRAX -71,033 -24.9%
CNTA -41,706 -100.0%
OLMA -31,252 -53.7%
BBOT -23,778 -14.9%
INSM -23,072 -74.3%
MAZE -22,388 -100.0%
BBIO -22,157 -35.1%
ASND -21,729 -100.0%
MLTX -21,105 -25.3%
TERN -15,816 -100.0%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type